Jane Street’s PDL BioPharma, Inc. PDLI Stock Holding History

Jane Street’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-58,463	Closed	-$184K	–	8551
2020 Q3	$184K	Sell	58,463 -156,096	-73%	-$499K	﹤0.01%	6484
2020 Q2	$624K	Buy	+214,559	New	+$679K	﹤0.01%	4736
2019 Q4	–	Sell	-45,103	Closed	-$97K	–	6196
2019 Q3	$97K	Sell	45,103 -21,561	-32%	-$57.6K	﹤0.01%	4802
2019 Q2	$209K	Buy	66,664 +24,029	+56%	+$77.9K	﹤0.01%	4649
2019 Q1	$159K	Buy	42,635 +21,718	+104%	+$73.3K	﹤0.01%	4706
2018 Q4	$61K	Sell	20,917 -4,517	-18%	-$12.4K	﹤0.01%	4708
2018 Q3	$67K	Buy	+25,434	New	+$62.4K	﹤0.01%	4900
2018 Q2	–	Sell	-26,652	Closed	-$78K	–	6071
2018 Q1	$78K	Sell	26,652 -25,320	-49%	-$69.1K	﹤0.01%	4637
2017 Q4	$142K	Buy	+51,972	New	+$160K	﹤0.01%	4292
2016 Q2	–	Sell	-13,709	Closed	-$46K	–	5004
2016 Q1	$46K	Buy	+13,709	New	+$42.7K	﹤0.01%	3955
2015 Q4	–	Sell	-47,409	Closed	-$238K	–	4856
2015 Q3	$238K	Buy	+47,409	New	+$272K	﹤0.01%	3010
2015 Q2	–	Sell	-24,875	Closed	-$175K	–	4403
2015 Q1	$175K	Sell	24,875 -4,929	-17%	-$35.7K	﹤0.01%	2932
2014 Q4	$230K	Sell	29,804 -44,227	-60%	-$350K	﹤0.01%	2107
2014 Q3	$553K	Buy	+74,031	New	+$687K	0.01%	1346
2014 Q2	–	Sell	-12,086	Closed	-$100K	–	3554
2014 Q1	$100K	Buy	+12,086	New	+$104K	﹤0.01%	2520
2013 Q4	–	Sell	-28,241	Closed	-$225K	–	3386
2013 Q3	$225K	Buy	+28,241	New	+$227K	﹤0.01%	2324

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Jane Street's PDLI Position: Q4 2020 in Review

Jane Street sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 58,463 shares — an estimated $184K sold.

Jane Street first reported a position in PDLI in Q3 2013 and held it in 16 quarters. The position peaked at $624K in Q2 2020. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

Jane Street reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
Jane Street sold 58,463 PDL BioPharma, Inc. shares in Q4 2020, an estimated $184K.
Jane Street first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 16 quarters.
Jane Street's PDL BioPharma, Inc. position peaked at $624K in Q2 2020.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.